Point of Care Coagulation Testing Products Market Size

Point of Care Coagulation Testing Products Market Size

Point of Care Coagulation Testing Products Market size was valued at USD 2.3 billion in 2022 and is estimated to account for USD 4.8 billion by 2032. Point-of-care coagulation testing products are medical devices designed to rapidly assess blood clotting at the point of care, beyond traditional laboratory settings. They offer swift and accurate coagulation information, facilitating immediate clinical decisions during surgeries, emergencies, and ongoing chronic care. Global point of care testing industry is set to witness over 7% CAGR from 2023 to 2032 owing to the growing prevalence of multiple medical diseases across developing countries.

To get key market trends

  Download Free Sample

These portable devices utilize small blood samples to measure clotting parameters, assisting in treatment monitoring and disorder diagnosis. The industry is driven by factors such as rising chronic blood disorders, government initiatives, convenient testing, technology advancements, home healthcare growth, aging population, and improved healthcare infrastructure in emerging markets.

Chronic blood disorders, such as hemophilia and thrombophilia, have been on the rise due to various factors including genetic predisposition, lifestyle changes, and an aging population. For instance, in 2022, data from the World Bleeding Disorders Registry (WBDR) reported that among 11,374 individuals with hemophilia across 115 treatment centers in 44 countries, only 30% of adults and 32% of children with severe hemophilia received prophylactic treatment.